Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative colitis 2024-05-21 12:01
Duoning Collaborates with Bioelectronica to Commercialize a Single-Cell Sorting System for Antibody Discovery 2024-05-20 20:00
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director 2024-05-20 18:00
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval 2024-05-20 14:07
Qilian International plans to adjust industrial investment 2024-05-17 22:00
GV Announces Cooperation with Top 500 Company in China 2024-05-17 20:30
Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference 2024-05-17 12:01
Visionary Has World-Class Biochip Technology Products 2024-05-16 20:30
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress 2024-05-16 09:03
/DISREGARD RELEASE: Visionary Holdings Inc./ 2024-05-15 23:01
Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients 2024-05-15 20:00
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer 2024-05-13 22:00
SK chemicals Targets the North American market with Circular Recycling Technology participating in NPE 2024 2024-05-13 21:00
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention 2024-05-11 15:14
Ribobay Pharma boosts CRDMO offerings with Cytiva's first FlexFactory platform for oligonucleotides 2024-05-10 18:39
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval 2024-05-10 12:16
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition cost 2024-05-10 07:41
Origin Agritech Receives GMO Safety Certificate for its Triple Stack Maize 2024-05-09 20:30
Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines 2024-05-09 15:30
NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia 2024-05-08 21:00
1 17 18 19 20 21 222